| Trial Identifier: | D8360C00001 |
| Sponsor: | AstraZeneca |
| NCTID:: | NCT03101839 |
| Start Date: | May 2017 |
| Primary Completion Date: | January 2019 |
| Study Completion Date: | January 2019 |
| Condition: | Cancer - Other; Lung Cancer |
For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.
| Language | Description |
| English Translation | |
| English Translation |
| Country | Location |
|---|---|
| United Kingdom | London, United Kingdom, W1G 6AD |
| United Kingdom | Manchester, United Kingdom, M20 4BX |
| United States of America, FL | Sarasota, FL, United States of America, 34232 |
| United States of America, MA | Boston, MA, United States of America, 02215 |
| United States of America, TN | Nashville, TN, United States of America, 37203 |
Powered by
Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.
Copyright © 2024 Pharma Intelligence UK Limited (Citeline), a Norstella company